SCHEDULE: FMR LLC Discloses 12% Stake in Boundless Bio Inc
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have reported a 12.0% beneficial ownership stake in Boundless Bio Inc's common stock as of December 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 2,684,022 shares of Boundless Bio Inc's common stock.
- This ownership represents 12.0% of the total outstanding common stock of Boundless Bio Inc.
- FMR LLC holds sole voting power over 2,681,049 shares and sole dispositive power over 2,684,022 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is also deemed to beneficially own the same 2,684,022 shares with sole dispositive power.
- A notable portion of this aggregate ownership, specifically 1,237,265 shares (5.5% of total outstanding), is held by Fidelity Growth Company Commingled Pool.
- The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Boundless Bio Inc.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as a substantial stake by a reputable institutional investor like FMR LLC often signals confidence in the issuer's long-term prospects and can attract further investor interest.
Positives
- A major institutional investor, FMR LLC (Fidelity), has taken a significant 12.0% beneficial ownership stake in Boundless Bio Inc.
- This substantial investment by a reputable firm can signal confidence in Boundless Bio Inc's long-term prospects and strategic direction.
Negatives
- The filing does not contain any negative information regarding Boundless Bio Inc's operations or financial performance.
Risks
- The filing, being a beneficial ownership disclosure, does not detail specific operational or financial risks pertaining to Boundless Bio Inc.
Future Outlook
The filing does not contain any forward-looking statements or guidance from Boundless Bio Inc or the reporting persons regarding the company's future performance or strategic direction.
Management Comments
- The filing includes certifications from FMR LLC and Abigail P. Johnson stating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that a significant stake by a major asset manager like FMR LLC (Fidelity) in a biotechnology company like Boundless Bio Inc can be interpreted as a vote of confidence in the company's potential, particularly given the capital-intensive and high-risk nature of the biotech sector. Such an investment often attracts attention from other institutional investors and can positively influence market perception.
Comparison to Industry Standards
- StockSavvy.ai observes that a 12.0% stake is a substantial position for an institutional investor in a publicly traded company, often placing them among the top shareholders.
- For instance, similar significant institutional holdings are seen in other emerging biotech firms where large funds like ARK Invest or BlackRock take positions, signaling belief in disruptive technologies or strong pipelines.
- While specific comparable companies are not mentioned in the filing, a stake of this magnitude suggests a long-term investment thesis, aligning with strategies employed by funds investing in high-growth, innovative sectors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Shareholder Voting Agreement | Members of the Johnson family, including Abigail P. Johnson, have a shareholders' voting agreement for Series B voting common shares of FMR LLC, ensuring all Series B shares are voted in accordance with the majority vote. | N/A | This agreement consolidates voting power within the Johnson family group regarding FMR LLC, which indirectly impacts the governance of companies FMR LLC invests in, including Boundless Bio Inc, by ensuring a unified investment strategy from the controlling entity. |
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor holding a 12.0% stake may increase confidence among existing shareholders and potentially attract new investors, potentially leading to positive share price movement.
- Management: The presence of a large, long-term institutional investor like FMR LLC could provide a degree of stability and potentially influence strategic decisions, although the filing states the investment is not for control purposes.
Next Steps
- The filing does not outline any specific future actions, events, or milestones for Boundless Bio Inc or the reporting persons beyond the ongoing beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 2023-01-10 | FMR LLC filed a Schedule 13G (accession number: -23-000003) incorporating the Power of Attorney. |
| 2023-01-26 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 2023-01-31 | FMR LLC filed a Schedule 13G (accession number: -23-000038) incorporating the Power of Attorney for Abigail P. Johnson. |
| 2025-12-31 | Date of the event which requires the filing of this statement (the reporting date for beneficial ownership). |
| 2026-02-04 | Date of signing and filing of this Schedule 13G Amendment No. 1. |
Recommendation
holdA significant 12.0% beneficial ownership by FMR LLC in Boundless Bio Inc indicates strong institutional confidence in the company. However, as this filing is solely an ownership disclosure and lacks detailed operational or financial performance data, a 'hold' recommendation is prudent. Investors should view this as a positive signal and conduct further due diligence into Boundless Bio Inc's fundamentals before making a 'buy' decision.
Keywords
Boundless Bio Inc, FMR LLC, Fidelity, Abigail P. Johnson, Beneficial Ownership, Institutional Investment, Common Stock, Schedule 13G, Biotechnology, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.